Masimo (NASDAQ:MASI) Stock Rating Upgraded by Stifel Nicolaus

Stifel Nicolaus upgraded shares of Masimo (NASDAQ:MASI) from a hold rating to a buy rating in a research note published on Monday, MarketBeat Ratings reports. They currently have $170.00 price target on the medical equipment provider’s stock, up from their prior price target of $148.00.

Other research analysts have also issued reports about the stock. Piper Sandler boosted their price objective on shares of Masimo from $70.00 to $117.00 and gave the stock a neutral rating in a research note on Monday, February 26th. Needham & Company LLC lowered shares of Masimo from a buy rating to a hold rating in a research note on Wednesday, January 3rd. Jefferies Financial Group reiterated a hold rating and issued a $121.00 price target (up previously from $107.00) on shares of Masimo in a research note on Tuesday, January 30th. Wells Fargo & Company upgraded shares of Masimo from an equal weight rating to an overweight rating and upped their price target for the company from $117.00 to $160.00 in a research note on Monday, March 25th. Finally, BTIG Research upped their price target on shares of Masimo from $145.00 to $166.00 and gave the company a buy rating in a research note on Monday, March 25th. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of Hold and an average target price of $137.43.

Masimo Stock Up 0.1 %

Masimo stock opened at $138.11 on Monday. The firm has a market capitalization of $7.31 billion, a PE ratio of 91.46 and a beta of 0.97. The company’s 50-day moving average is $135.48 and its 200-day moving average is $113.18. Masimo has a fifty-two week low of $75.22 and a fifty-two week high of $198.00. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.18 and a quick ratio of 1.22.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, February 27th. The medical equipment provider reported $1.25 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.43. The company had revenue of $548.90 million for the quarter, compared to analyst estimates of $545.69 million. Masimo had a net margin of 3.98% and a return on equity of 13.77%. Masimo’s revenue for the quarter was down 11.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 EPS. Sell-side analysts anticipate that Masimo will post 3.51 earnings per share for the current year.

Institutional Trading of Masimo

Institutional investors have recently bought and sold shares of the business. Eminence Capital LP bought a new stake in Masimo in the 3rd quarter valued at about $90,859,000. Teachers Retirement System of The State of Kentucky boosted its holdings in Masimo by 93.8% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 16,541 shares of the medical equipment provider’s stock valued at $1,450,000 after purchasing an additional 8,004 shares during the period. Comerica Bank bought a new stake in Masimo in the 3rd quarter valued at about $8,454,000. Sei Investments Co. lifted its holdings in shares of Masimo by 224.5% during the 3rd quarter. Sei Investments Co. now owns 183,940 shares of the medical equipment provider’s stock worth $16,128,000 after acquiring an additional 127,249 shares during the period. Finally, Massachusetts Financial Services Co. MA bought a new stake in shares of Masimo during the 3rd quarter worth approximately $132,699,000. Institutional investors own 85.96% of the company’s stock.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.